These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30548714)

  • 21. How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016-2020 International Tobacco Control United States surveys.
    He Y; Liber A; Driezen P; Thompson ME; Levy DT; Fong GT; Cummings KM; Shang C
    Addiction; 2024 May; 119(5):885-897. PubMed ID: 38186201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Don't Know" Responses for Nicotine Vaping Product Features among Adult Vapers: Findings from the 2018 and 2020 ITC Four Country Smoking and Vaping Surveys.
    Felicione NJ; Cummings KM; Gravely S; Hammond D; McNeill A; Borland R; Fong GT; O'Connor RJ
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaping characteristics and expectancies are associated with smoking cessation propensity among dual users of combustible and electronic cigarettes.
    Brandon KO; Simmons VN; Meltzer LR; Drobes DJ; Martínez Ú; Sutton SK; Palmer AM; Bullen CR; Harrell PT; Brandon TH
    Addiction; 2019 May; 114(5):896-906. PubMed ID: 30644627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in cigarette smoking quit attempts and cessation between adults who did and did not take up nicotine vaping: Findings from the ITC four country smoking and vaping surveys.
    Gravely S; Meng G; Hammond D; Hyland A; Michael Cummings K; Borland R; Kasza KA; Yong HH; Thompson ME; Quah ACK; Ouimet J; Martin N; O'Connor RJ; East KA; McNeill A; Boudreau C; Levy DT; Sweanor DT; Fong GT
    Addict Behav; 2022 Sep; 132():107339. PubMed ID: 35605409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia.
    Erku DA; Gartner CE; Tengphakwaen U; Morphett K; Steadman KJ
    Drug Alcohol Rev; 2019 Sep; 38(6):703-711. PubMed ID: 31486151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prices, use restrictions and electronic cigarette use-evidence from wave 1 (2016) US data of the ITC Four Country Smoking and Vaping Survey.
    Cheng KW; Chaloupka FJ; Shang C; Ngo A; Fong GT; Borland R; Heckman BW; Levy DT; Cummings KM
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):115-122. PubMed ID: 30690802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Does the Use of Flavored Nicotine Vaping Products Relate to Progression Toward Quitting Smoking? Findings From the 2016 and 2018 ITC 4CV Surveys.
    Li L; Borland R; Cummings KM; Fong GT; Gravely S; Smith DM; Goniewicz ML; O'Connor RJ; Thompson ME; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1490-1497. PubMed ID: 33631007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study.
    Levy DT; Meza R; Yuan Z; Li Y; Cadham C; Sanchez-Romero LM; Travis N; Knoll M; Liber AC; Mistry R; Hirschtick JL; Fleischer NL; Skolnick S; Brouwer AF; Douglas C; Jeon J; Cook S; Warner KE
    Tob Control; 2023 Apr; 32(e1):e37-e44. PubMed ID: 34475258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceptions of harmfulness of heated tobacco and nicotine vaping products compared to cigarettes, and the association of advertising exposure on harm perceptions among adults who smoke in South Korea: Cross-sectional findings from the 2020 ITC Korea Survey.
    Goulette MR; Gravely S; Xu SS; Meng G; Quah ACK; Lee S; Cho SI; Kim Y; Lim S; Bansal-Travers M; Hyland A; Fong GT; Seo HG
    Tob Induc Dis; 2023; 21():121. PubMed ID: 37781238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying factors that conjointly influence nicotine vaping product relative harm perception among smokers and recent ex-smokers: Findings from the 2016 ITC Four Country Smoking and Vaping Survey.
    Yong HH; Karmakar C; Motin MA; Borland R; Elton-Marshall T; Cummings KM; Fong GT; Thompson ME
    Drug Alcohol Depend; 2021 Jan; 218():108370. PubMed ID: 33139154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure to and perceptions of health warning labels on nicotine vaping products: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey.
    McDermott MS; Li G; McNeill A; Hammond D; Thrasher JF; O'Connor RJ; Cummings KM; Borland R; Fong GT; Hitchman SC
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):134-143. PubMed ID: 30618081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
    Li L; Borland R; Cummings KM; Gravely S; Quah ACK; Fong GT; Miller CR; Goniewicz ML; Le Grande M; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1611-1616. PubMed ID: 33693833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing identity, attitudes, and indicators of effectiveness in people who smoke, vape or use heated tobacco products: A cross-sectional study.
    Kale D; Brown J; Dawkins L; Goniewicz ML; Leppin C; Tattan-Birch H; Shahab L
    Addict Behav; 2024 Apr; 151():107933. PubMed ID: 38142579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of vaping: evidence from ITC Four Country Smoking and Vaping Survey.
    Cheng KW; Shang C; Lee HM; Chaloupka FJ; Fong GT; Borland R; Heckman BW; Hitchman SC; O'Connor RJ; Levy DT; Cummings KM
    Tob Control; 2021 Jan; 30(1):94-97. PubMed ID: 32086385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?
    Borland R; Le Grande M; Gartner C; Morphett K
    Int J Drug Policy; 2024 Jun; 128():104460. PubMed ID: 38776582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation.
    Warner KE; Mendez D
    Nicotine Tob Res; 2019 Jan; 21(1):41-47. PubMed ID: 29617887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Does Smoking and Nicotine Dependence Change After Onset of Vaping? A Retrospective Analysis of Dual Users.
    Martínez Ú; Martínez-Loredo V; Simmons VN; Meltzer LR; Drobes DJ; Brandon KO; Palmer AM; Eissenberg T; Bullen CR; Harrell PT; Brandon TH
    Nicotine Tob Res; 2020 Apr; 22(5):764-770. PubMed ID: 30883640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals.
    Morphett K; Holland A; Ward S; Steadman KJ; Zwar NA; Gartner C
    Int J Drug Policy; 2024 Mar; 125():104353. PubMed ID: 38364356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States.
    Levy DT; Borland R; Villanti AC; Niaura R; Yuan Z; Zhang Y; Meza R; Holford TR; Fong GT; Cummings KM; Abrams DB
    Nicotine Tob Res; 2017 Feb; 19(2):149-159. PubMed ID: 27613952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indicators of cigarette smoking dependence and relapse in former smokers who vape compared with those who do not: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey.
    McNeill A; Driezen P; Hitchman SC; Cummings KM; Fong GT; Borland R
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):49-60. PubMed ID: 31225672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.